Shenzhen Salubris Pharmaceuticals Co., Ltd. (SHE:002294)

China flag China · Delayed Price · Currency is CNY
52.07
-1.02 (-1.92%)
Apr 29, 2026, 10:25 AM CST
31.32%
Market Cap 59.19B
Revenue (ttm) 4.52B
Net Income (ttm) 676.45M
Shares Out 1.11B
EPS (ttm) 0.60
PE Ratio 88.42
Forward PE 74.77
Dividend 0.55 (1.01%)
Ex-Dividend Date May 14, 2025
Volume 4,378,800
Average Volume 13,880,235
Open 55.60
Previous Close 53.09
Day's Range 51.91 - 55.60
52-Week Range 36.81 - 70.99
Beta 0.19
RSI 39.41
Earnings Date Apr 21, 2026

About SHE:002294

Shenzhen Salubris Pharmaceuticals Co., Ltd. engages in the research, development, production, and sale of pharmaceuticals and medical devices in China. The company is involved in the production and supply of pharmaceutical products in the fields of chronic diseases, including cardiovascular and cerebrovascular diseases, diabetes, oncology, osteoporosis, anti-infective diseases, and chronic kidney diseases. It also engages in the research and development, production, and sale of high-end interventional medical devices, such as cardiovascular and... [Read more]

Sector Healthcare
Founded 1998
Employees 3,596
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002294
Full Company Profile

Financial Performance

In 2025, SHE:002294's revenue was 4.35 billion, an increase of 8.48% compared to the previous year's 4.01 billion. Earnings were 651.50 million, an increase of 8.30%.

Financial Statements

News

There is no news available yet.